01 11Decapeptyl
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 472
2019 Revenue in Millions : 493
Growth (%) : -4
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 506
2020 Revenue in Millions : 472
Growth (%) : 18
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 568
2021 Revenue in Millions : 506
Growth (%) : 12
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 589
2022 Revenue in Millions : 568
Growth (%) : 3
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 556
2023 Revenue in Millions : 589
Growth (%) : -6
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2015 Revenue in Millions : 349
2014 Revenue in Millions : 367
Growth (%) : 5%
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2016 Revenue in Millions : 360
2015 Revenue in Millions : 354
Growth (%) : 2
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2017 Revenue in Millions : 432
2016 Revenue in Millions : 421
Growth (%) : 3
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2018 Revenue in Millions : 421
2017 Revenue in Millions : 394
Growth (%) : 7%
Main Therapeutic Indication : Hormonal Disorders
Currency : USD
2014 Revenue in Millions : 7%
2013 Revenue in Millions :
Growth (%) :
